KELLY JUEDEN: Open Payments
NPI 1679868301 · NORFOLK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 68 payments from 20 companies in 2025. Trend: 2023 $1,383 · 2024 $713 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $271 |
| AstraZeneca Pharmaceuticals LP | 10 | $151 |
| Lilly USA, LLC | 9 | $144 |
| Novo Nordisk Inc | 4 | $70 |
| Corcept Therapeutics | 3 | $57 |
| Amgen Inc. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| PFIZER INC. | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 5 | $35 |
Products named: JARDIANCE, UBRELVY, MOUNJARO, BOTOX, QULIPTA, Korlym, Wegovy, EVENITY.
Industry payments across NE — which companies pay providers there.
